Biognosys closes Series G round with new and existing investors to accelerate implementation of discovery proteomics in clinical trials. SCHLIEREN, (Zurich, Switzerland). Biognosys, a Swiss proteomics company, continues realizing its ambition to enable clinical researchers to directly measure and quantify thousands of proteins from patient tissues in clinical trials by offering its next-generation label-free proteomics technology. […]
Bournemouth, UK: Solentim, the innovator and World leader in Cell Line Development instrumentation, is pleased to announce that it achieved very strong revenue growth and financial results for the first half of 2019. Commenting on the performance, Dr Ian Taylor, Chief Commercial Officer noted “Our results are in line with the current surge in the bioprocessing […]
Grant to Automate Variant Interpretation and Create Platform for Sharing Micropublications Across the Genomics Community Genomenon, Inc., the leading genomic search engine company, announced today that it was awarded a grant by the National Institutes of Health. The Small Business Innovation Research (SBIR) grant, awarded by the National Human Genome Research Institute*, will fund Genomenon’s […]
New Funding, Anticipated to Close at $22 Million, to Fuel Growth of its Regenerative Medicine MSC Manufacturing Platform Worldwide, Scale the Organization, and Accelerate R&D Innovation Frederick, MD, Aug. 6 — RoosterBio Inc, disrupting the market by radically simplifying human mesenchymal stem/stromal cell (hMSC) biomanufacturing, today announced it has raised in excess of $15 million in an initial Series B financing […]
Applied DNA and TheraCann International Sign Term Sheet to Amend Licensing and Cooperation Agreement
Amendments fortify the Agreement, allow revenue recognition, and strengthen the Applied DNA Balance Sheet STONY BROOK, N.Y. – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based (Polymerase Chain Reaction) DNA manufacturing for product authenticity and traceability solutions, today announced that the Company and TheraCann International Benchmark Corporation (“TheraCann”) have signed a […]
Khosla Ventures leads Series A investment in human tissue engineering company Prellis, backing Prellis’ mission to create viable human tissue and organs for research and transplant IMAGE: PRELLIS STRUCTURE TRANSPLANTED ALONE IS SURROUNDED BY SINGLE CELL WALLED CAPILLARIES WITHIN TWO WEEKS OF TRANSPLANTATION INTO IMMUNOCOMPETENT MOUSE (LEFT). HUMAN TUMOR CELLS TRANSPLANTED IN PRELLIS STRUCTURES GROW RAPIDLY, […]
Southborough, MA Block MEMS, a leading developer of Quantum Cascade Laser (QCL) based infrared detection systems, has been awarded a $3.5M contract from the Defense Advanced Research Agency (DARPA), as part of the SIGMA+ Program. The goal of the program is to develop a persistent, real-time, early detection system for the full spectrum of chemical, […]
Khosla Ventures leads Series A investment in human tissue engineering company Prellis, backing Prellis’ mission to create viable human tissue and organs for research and transplant San Francisco, CA–Prellis Biologics today announced that Khosla Ventures has led an $8.7 million Series A investment in the company. The announcement comes as Prellis has reached major tissue engineering […]
908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecular analysis, announced it has been awarded a technical project grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). This award will fuel continued development of simple, at-line bioreactor process analytics – a collaboration between 908 Devices, MilliporeSigma, the University of North Carolina at Chapel Hill, […]
Menlo Ventures leads Series C to power global expansion, extend product lead and deepen commercial relationships to accelerate biotech breakthroughs SAN FRANCISCO — Benchling, the leading life sciences R&D cloud platform, announced it closed $34.5 million in Series C funding led by Menlo Ventures with new investors Lead Edge Capital and Y Combinator Continuity as well as returning investors […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
